Zhuo Wang
334 Jungong Road
Shanghai, 200093, China
Shanghai, 200093, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Oxygen vacancies-induced dual-interface modulation for TiO2/BiOI-based photoelectrochemical biosensor of urinary cancer markers.
Journal: Biosensors & bioelectronics
Published: June 05, 2026
SAI-RRT*: Safety-Aware Informed RRT* for Multi-Joint Manipulator Path Planning in Static Environments.
Journal: Sensors (Basel, Switzerland)
Published: May 18, 2026
Analytical Considerations and Often-Overlooked Aspects in the Therapeutic Drug Monitoring of Polymyxins in Human Biological Matrices Using LC-MS/MS.
Journal: Critical reviews in analytical chemistry
Published: April 28, 2026
M2 macrophage-mediated tigecycline nanoparticles for combating CRKP pneumonia via antibacterial and immunomodulatory therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 11, 2025
Cell-based drug delivery for combating bacteria: focus on refractory infections.
Journal: Journal of nanobiotechnology
Published: November 20, 2025
Antibacterial potential of danthron, embelin, sanguinarine and shikonin against multidrug-resistant Neisseria gonorrhoeae in vitro.
Journal: International microbiology : the official journal of the Spanish Society for Microbiology
Published: October 31, 2025
Panel of three cytokines predicts occurrence of aGVHD after allo-HSCT: a retrospective study.
Journal: Frontiers in immunology
Published: October 06, 2025
Association of CYP3A5 rs15524 and CYP3A7 rs776744 polymorphisms on tac IPV and clinical outcomes in early post-heart transplantation.
Journal: BMC medical genomics
Published: June 30, 2025
Evaluating Chelerythrine Chloride as a Potential Treatment for Multidrug-Resistant Gonorrhea.
Journal: Infection and drug resistance
Published: May 07, 2025
Nanomaterials: An innovative integrative paradigm for hepatocellular carcinoma adjuvant treatment.
Journal: Asian journal of pharmaceutical sciences
Published: March 02, 2025
Composite outcome of oral azvudine vs. nirmatrelvir-ritonavir in COVID-19 patients: a retrospective cohort study.
Journal: Frontiers in pharmacology
Published: January 22, 2025
Last Updated: 09/26/2026